[1]
García, M.C. 2019. Treatment of borderline personality disorder with opioid antagonists: buprenorphine, nalmefene, naloxone and naltrexone in the treatment of dissociative symptoms, self-mutilation and suicidal behavior. Vertex Revista Argentina de Psiquiatría. 30, 148, nov.-dic. (Dec. 2019), 405–414. DOI:https://doi.org/10.53680/vertex.v30i148.122.